Asian data collection for CNS germ cell tumors
Part of Brain & nervous system, Cancer clinical trials.
This trial is creating a consortium to collect data from Asian patients with CNS germ cell tumors. It helps researchers understand these tumors better and may lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a central nervous system (CNS) germ cell tumor between 2016 and 2027.
- You were diagnosed at age 40 or younger.
- Your tumor was confirmed by surgery or biopsy, OR if you have a germinoma, you meet special criteria (radiology suspicion and normal or specific tumor markers).
- You or your guardian has agreed to take part in this research study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a new treatment approach for certain brain tumors called NGGCT in children and young adults. It may help improve outcomes by targeting tumors in specific brain locations and using tumor marker tests to guide care.
This trial will see if giving a lower dose of radiation therapy can still effectively treat children and young adults with a type of brain tumor called germinoma. The goal is to reduce side effects while keeping the cancer under control.
This is an observational study that collects and compares information from patients with primary brain tumors and their treatment results. It uses stored tumor tissue and brain scans to better understand outcomes using updated tumor classification methods.
This study looks at “molecular” (DNA-related) features of germ cell tumors in children and teens. It also follows patients over time, which can help researchers understand tumor patterns and improve future care.
This Phase 2 trial studies WVI for children and young adults with a newly diagnosed germ cell tumor in one side of the basal ganglia/thalamus. It aims to see how well the treatment works for tumors without spread within the brain.
This trial studies how brain tumors (like high-risk gliomas, medulloblastoma, and ependymoma) respond to treatment and why they sometimes become resistant. It is for young people aged 15 to 39 and aims to use tumor tissue samples to understand the tumor better and guide future therapies.
Hear when a new CNS Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.